Koyfin Home > Directory > Health Care > Acorda Therapeutics > Return on Equity %

Acorda Therapeutics Return on Equity % Chart (ACOR)

Acorda Therapeutics annual/quarterly Return on Equity % from 2010 to 2020.
  • Acorda Therapeutics Return on Equity % for the quarter ending June 06, 2020 was -23.32 a -994.18% increase of 231.86 year over year
  • Acorda Therapeutics Return on Equity % for the last 12 months ending June 06, 2020 was -53.07 a -40.91% increase of 21.71 year over year
  • Acorda Therapeutics Annual Return on Equity % for 2019 was -59.16 a 110.06% decrease of -65.11 from 2018
  • Acorda Therapeutics Annual Return on Equity % for 2018 was 5.95 a 733.90% increase of 43.67 from 2017
  • Acorda Therapeutics Annual Return on Equity % for 2017 was -37.72 a 85.10% decrease of -32.10 from 2016
Other Margins & Efficiency Metrics:
  • Acorda Therapeutics EBITDA Margin for the quarter ending December 12, 2018 was $-20m a 159.12% decrease of -32m year over year
  • Acorda Therapeutics Return on Capital % for the quarter ending December 12, 2018 was -4.27 a 144.67% decrease of -6.18 year over year
View Chart On Koyfin

Quarterly ACOR Return on Equity % Data

06/2020-23.32
03/2020-8.38
12/201988.71
09/2019-255.18
06/2019-19.78
03/2019-32.31
12/20186.34
09/2018-9.23
06/201831.95
03/2018-6.13

Annual ACOR Return on Equity % Data

2019-59.16
20185.95
2017-37.72
2016-5.62
20151.93
20143.60
20133.98
201252.43
201117.17
2010-8.16